Noveris Health Sciences is trading at CA$0.08, down 5.88%, in an unattributed move; no new company-specific announcement dated September 25, 2026 was identified.
- The latest listed corporate items were earlier releases, including the September 4 annual meeting results.
- Broader biotech and rate-sensitive growth-stock weakness may be contributing, but today’s major U.S. indices are modestly higher, limiting confidence in a market-wide explanation.